Home > Insider Trading > Filing (0001140361-11-032028)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1401782	Mark Wood	C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949	Vp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-06	1,250	$0.00	20,461	No	4	M	Direct
Common Stock	Disposition	2011-06-07	456	$27.46	20,005	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2011-06-06	1,250	$0.00	1,250	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,250	2011-06-07		No	4	M	Direct

Footnotes

Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.
Transaction made pursuant to a Rule 10b5-1 Trading Plan executed on September 7, 2010.
The price in Column 4 is a weighted average price. The prices actually received ranged from $27.39 to $27.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 7, 2010 and June 7, 2011.